Moderate-Intensity Exercise and Musical Co-Treatment Decreased the Circulating Level of Betatrophin

Abstract EN

Introduction.

In general, the significant contribution of lack of physical activity is strongly correlated with lipid metabolism and metabolic disorder.

Hitherto, betatrophin is a potential hormone that regulates the lipid profile in the body circulation-associated triglyceride level.

This study was designed to evaluate the alteration of betatrophin levels in subject-onset hypertriglyceridemia with exercise intervention co-treated with music.

Materials and Methods.

A total of 60 nonprofessional athletes were enrolled in this study and given moderate-intensity exercise (MIE) combined with middle rhythm musical co-treatment.

The ELISA method was applied to quantify the serum level of betatrophin in all samples.

The statistical analysis was performed by applying the Kolmogorov–Smirnov normality test, one-way ANOVA, and parametric linear correlation and regression.

Results.

Interestingly, our data show that MIE decreased the circulating level of betatrophin combined with music (12.47 ± 0.40 ng/mL) compared with that without musical co-treatment (20.81 ± 1.16 ng/mL) and high-intensity exercise (26.91 ± 2.23 ng/mL).

The plasma level of betatrophin was positively correlated with triglycerides (r = 0.316, p≤0.05), systolic blood pressure (r = 0.428, p≤0.01), HDL (r = 0.366, p≤0.05), energy expenditure (r = 0.586, p≤0.001), PGC-1α (r = 0.573, p≤0.001), and irisin (r = 0.863, p≤0.001).

By contrast, the plasma level of betatrophin was negatively associated with age (r = −0.298, p≤0.05) and LDL cholesterol (r = −0.372, p≤0.05).

Importantly, betatrophin is a significant predictor for energy expenditure (p≤0.001) and plasma triglyceride levels (p≤0.05).

Conclusions.

Our data demonstrate that betatrophin levels decreased the post-MIE and musical therapeutical combination.

Therefore, betatrophin may provide a benefit as the potential biomarker of physiological performance-associated physical training.